Structural Plasticity Underpins Promiscuous Binding of the Prosurvival Protein A1

Structure

Volumn 16, Issue 5, 2008, Pages 818-829

  Smits, Callum ^a   Czabotar, Peter E ^b   Hinds, Mark G ^b   Day, Catherine L ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

PROTEINS

Indexed keywords

BH3 PROTEIN; PROSURVIVAL PROTEIN A1; PROTEIN; PROTEIN BAK; PROTEIN BID; PUMA PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASTICITY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN STRUCTURE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; APOPTOSIS REGULATORY PROTEINS; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; CRYSTALLOGRAPHY, X-RAY; GLUTATHIONE TRANSFERASE; HUMANS; HYDROPHOBICITY; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROLINE; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; SOLUBILITY;

EID: 42949110343     PISSN: 09692126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.str.2008.02.009     Document Type: Article

References (51)

1. Adams J.M., and Cory S. The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 26 (2007) 1324-1337
2. Alexov E.G., and Gunner M.R. Incorporating protein conformational flexibility into the calculation of pH-dependent protein properties. Biophys. J. 72 (1997) 2075-2093
3. Brien G., Trescol-Biemont M.C., and Bonnefoy-Berard N. Downregulation of Bfl-1 protein expression sensitizes malignant B cells to apoptosis. Oncogene 26 (2007) 5828-5832
4. CCP4 (Collaborative Computational Project, Number 4). The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D Biol. Crystallogr. 50 (1994) 760-763
5. Chen L., Willis S.N., Wei A., Smith B.J., Fletcher J.I., Hinds M.G., Colman P.M., Day C.L., Adams J.M., and Huang D.C. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol. Cell 17 (2005) 393-403
6. Cheng Y., and Prusoff W.H. Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol. 22 (1973) 3099-3108
7. Choi S.S., Park I.C., Yun J.W., Sung Y.C., Hong S.I., and Shin H.S. A novel Bcl-2 related gene, Bfl-1, is overexpressed in stomach cancer and preferentially expressed in bone marrow. Oncogene 11 (1995) 1693-1698
8. Choi S.S., Park S.H., Kim U.J., and Shin H.S. Bfl-1, a Bcl-2-related gene, is the human homolog of the murine A1, and maps to chromosome 15q24.3. Mamm. Genome 8 (1997) 781-782
9. Czabotar P.E., Lee E.F., van Delft M.F., Day C.L., Smith B.J., Huang D.C., Fairlie W.D., Hinds M.G., and Colman P.M. Structural insights into the degradation of Mcl-1 induced by BH3 domains. Proc. Natl. Acad. Sci. USA 104 (2007) 6217-6222
10. Dao-pin S., Anderson D.E., Baase W.A., Dahlquist F.W., and Matthews B.W. Structural and thermodynamic consequences of burying a charged residue within the hydrophobic core of T4 lysozyme. Biochemistry 30 (1991) 11521-11529
11. Dao-pin S., Sauer U., Nicholson H., and Matthews B.W. Contributions of engineered surface salt bridges to the stability of T4 lysozyme determined by directed mutagenesis. Biochemistry 30 (1991) 7142-7153
12. Day C.L., Chen L., Richardson S.J., Harrison P.J., Huang D.C., and Hinds M.G. Solution structure of prosurvival Mcl-1 and characterization of its binding by proapoptotic BH3-only ligands. J. Biol. Chem. 280 (2005) 4738-4744
13. DeLano W.L. The PYMOL Molecular Graphics System (2002), DeLano Scientific, Palo Alto, CA
14. Emsley P., and Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60 (2004) 2126-2132
15. Fesik S.W. Promoting apoptosis as a strategy for cancer drug discovery. Nat. Rev. Cancer 5 (2005) 876-885
16. Georgescu R.E., Alexov E.G., and Gunner M.R. Combining conformational flexibility and continuum electrostatics for calculating pK(a)s in proteins. Biophys. J. 83 (2002) 1731-1748
17. Hamasaki A., Sendo F., Nakayama K., Ishida N., Negishi I., Nakayama K., and Hatakeyama S. Accelerated neutrophil apoptosis in mice lacking A1-a, a subtype of the bcl-2-related A1 gene. J. Exp. Med. 188 (1998) 1985-1992
18. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
19. Hatakeyama S., Hamasaki A., Negishi I., Loh D.Y., Sendo F., Nakayama K., and Nakayama K. Multiple gene duplication and expression of mouse bcl-2-related genes, A1. Int. Immunol. 10 (1998) 631-637
20. Hinds M.G., and Day C.L. Regulation of apoptosis: uncovering the binding determinants. Curr. Opin. Struct. Biol. 15 (2005) 690-699
21. Hinds M.G., Lackmann M., Skea G.L., Harrison P.J., Huang D.C., and Day C.L. The structure of Bcl-w reveals a role for the C-terminal residues in modulating biological activity. EMBO J. 22 (2003) 1497-1507
22. Hinds M.G., Smits C., Fredericks-Short R., Risk J.M., Bailey M., Huang D.C., and Day C.L. Bim, Bad and Bmf: intrinsically unstructured BH3-only proteins that undergo a localized conformational change upon binding to prosurvival Bcl-2 targets. Cell Death Differ. 14 (2007) 128-136
23. Horovitz A., Serrano L., Avron B., Bycroft M., and Fersht A.R. Strength and co-operativity of contributions of surface salt bridges to protein stability. J. Mol. Biol. 216 (1990) 1031-1044
24. Huang D.C., and Strasser A. BH3-only proteins-essential initiators of apoptotic cell death. Cell 103 (2000) 839-842
25. Jelesarov I., and Bosshard H.R. Isothermal titration calorimetry and differential scanning calorimetry as complementary tools to investigate the energetics of biomolecular recognition. J. Mol. Recognit. 12 (1999) 3-18
26. Karsan A., Yee E., Kaushansky K., and Harlan J.M. Cloning of human Bcl-2 homologue: inflammatory cytokines induce human A1 in cultured endothelial cells. Blood 87 (1996) 3089-3096
27. Kim R., Sandler S.J., Goldman S., Yokota H., Clark A.J., and Kim S. Overexpression of archaeal proteins in Escherichia coli. Biotechnol. Lett. 20 (1998) 207-210
28. Konopleva M., Contractor R., Tsao T., Samudio I., Ruvolo P.P., Kitada S., Deng X., Zhai D., Shi Y.X., Sneed T., et al. Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia. Cancer Cell 10 (2006) 375-388
29. Lawrence M.C., and Colman P.M. Shape complementarity at protein/protein interfaces. J. Mol. Biol. 234 (1993) 946-950
30. Lee E.F., Czabotar P.E., Smith B.J., Deshayes K., Zobel K., Colman P.M., and Fairlie W.D. Crystal structure of ABT-737 complexed with Bcl-xL: implications for selectivity of antagonists of the Bcl-2 family. Cell Death Differ. 14 (2007) 1711-1713
31. Leslie A.G. Integration of macromolecular diffraction data. Acta Crystallogr. D Biol. Crystallogr. 55 (1999) 1696-1702
32. Letai A., Bassik M.C., Walensky L.D., Sorcinelli M.D., Weiler S., and Korsmeyer S.J. Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell 2 (2002) 183-192
33. Lin E.Y., Orlofsky A., Berger M.S., and Prystowsky M.B. Characterization of A1, a novel hemopoietic-specific early-response gene with sequence similarity to bcl-2. J. Immunol. 151 (1993) 1979-1988
34. Lindsten T., Ross A.J., King A., Zong W.X., Rathmell J.C., Shiels H.A., Ulrich E., Waymire K.G., Mahar P., Frauwirth K., et al. The combined functions of proapoptotic Bcl-2 family members Bak and Bax are essential for normal development of multiple tissues. Mol. Cell 6 (2000) 1389-1399
35. Liu X., Dai S., Zhu Y., Marrack P., and Kappler J.W. The structure of a Bcl-xL/Bim fragment complex: implications for Bim function. Immunity 19 (2003) 341-352
36. Lu G. TOP: a new method for protein structure comparisons and similarity searches. J. Appl. Crystallogr. 33 (2000) 176-183
37. McCoy A.J., Grosse-Kunstleve R.W., Storoni L.C., and Read R.J. Likelihood-enhanced fast translation functions. Acta Crystallogr. D Biol. Crystallogr. 61 (2005) 458-464
38. Morales A.A., Olsson A., Celsing F., Osterborg A., Jondal M., and Osorio L.M. High expression of bfl-1 contributes to the apoptosis resistant phenotype in B-cell chronic lymphocytic leukemia. Int. J. Cancer 113 (2005) 730-737
39. Murshudov G.N., Vagin A.A., and Dodson E.J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D Biol. Crystallogr. 53 (1997) 240-255
40. Oltersdorf T., Elmore S.W., Shoemaker A.R., Armstrong R.C., Augeri D.J., Belli B.A., Bruncko M., Deckwerth T.L., Dinges J., Hajduk P.J., et al. An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 435 (2005) 677-681
41. Otwinowski Z., and Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276 (1997) 307-326
42. Petros A.M., Olejniczak E.T., and Fesik S.W. Structural biology of the Bcl-2 family of proteins. Biochim. Biophys. Acta 1644 (2004) 83-94
43. Petros A.M., Dinges J., Augeri D.J., Baumeister S.A., Betebenner D.A., Bures M.G., Elmore S.W., Hajduk P.J., Joseph M.K., Landis S.K., et al. Discovery of a potent inhibitor of the antiapoptotic protein Bcl-xL from NMR and parallel synthesis. J. Med. Chem. 49 (2006) 656-663
44. Sattler M., Liang H., Nettesheim D., Meadows R.P., Harlan J.E., Eberstadt M., Yoon H.S., Shuker S.B., Chang B.S., Minn A.J., et al. Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis. Science 275 (1997) 983-986
45. Sheldrick G.M., Dauter Z., Wilson K.S., Hope H., and Sieker L.C. The application of direct methods and Patterson interpretation to high-resolution native protein data. Acta Crystallogr. D Biol. Crystallogr. 49 (1993) 18-23
46. Simmons M.J., Fan G., Zong W.X., Degenhardt K., White E., and Gelinas C. Bfl-1/A1 functions, similar to Mcl-1, as a selective tBid and Bak antagonist. Oncogene 27 (2008) 1421-1428
47. Studier F.W. Protein production by auto-induction in high density shaking cultures. Protein Expr. Purif. 41 (2005) 207-234
48. van Delft M.F., Wei A.H., Mason K.D., Vandenberg C.J., Chen L., Czabotar P.E., Willis S.N., Scott C.L., Day C.L., Cory S., et al. The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized. Cancer Cell 10 (2006) 389-399
49. Wei M.C., Zong W.X., Cheng E.H., Lindsten T., Panoutsakopoulou V., Ross A.J., Roth K.A., MacGregor G.R., Thompson C.B., and Korsmeyer S.J. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292 (2001) 727-730
50. Willis S.N., Chen L., Dewson G., Wei A., Naik E., Fletcher J.I., Adams J.M., and Huang D.C. Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. Genes Dev. 19 (2005) 1294-1305
51. Zong W.X., Lindsten T., Ross A.J., MacGregor G.R., and Thompson C.B. BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak. Genes Dev. 15 (2001) 1481-1486